PATTERN OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) PRESENTATION AND TREATMENT RESPONSE IN PRIMARY SCHOOL CHILDREN

Main Article Content

Dr Pradeep Kumar Jain

Keywords

ADHD, Primary School Children, Treatment Response, Presentation Patterns, Pediatric Psychiatry

Abstract

Introduction: Attention Deficit Hyperactivity Disorder (ADHD) affects 5-12% of school-aged children worldwide, yet presentation patterns and treatment responses vary significantly across subtypes. This study investigated ADHD presentation characteristics and therapeutic outcomes in primary school children to inform evidence-based clinical practice and optimize treatment approaches.


Methods: A prospective observational study was conducted at Saraswati Institute of Medical Science, Hapur, from June to December 2013. One hundred eighty children aged 6-12 years with confirmed ADHD diagnosis were enrolled using systematic sampling. Participants underwent comprehensive assessment using standardized instruments including Vanderbilt ADHD Rating Scales, Conners' Rating Scales, and Clinical Global Impression scales. Treatment response, functional outcomes, and safety profiles were monitored over 12 weeks using validated measures.


Results: Combined type ADHD was most prevalent (49.4%), followed by inattentive (37.2%) and hyperactive-impulsive (13.3%) subtypes. Overall comorbidity rate reached 77.2%, with oppositional defiant disorder being most common (37.8%). Treatment response rates were encouraging across subtypes (73.3% overall), with inattentive type showing highest response rates (77.6%) and hyperactive-impulsive type demonstrating fastest response onset (4.8±2.1 weeks). Significant functional improvements occurred in quality of life (+14.6 points), school functioning (+17.8 points), and family dynamics. Adverse effects occurred in 60.6% of medicated children, primarily appetite suppression (45.1%) and sleep difficulties (26.8%).


Conclusion: ADHD subtypes demonstrate distinct presentation and treatment response patterns. Combined multimodal approaches yield significant symptom reduction and functional improvements with acceptable safety profiles, supporting individualized treatment strategies based on subtype characteristics and comorbidity patterns.


 

Abstract 56 | PDF Downloads 11

References

1. Biederman, J. (2005). Attention-deficit/hyperactivity disorder: A selective overview. Biological Psychiatry, 57(11), 1215-1220. https://doi.org/10.1016/j.biopsych.2004.10.020
2. Biederman, J., & Faraone, S. V. (2005). Attention-deficit hyperactivity disorder. The Lancet, 366(9481), 237-248. https://doi.org/10.1016/S0140-6736(05)66915-2
3. Biederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., Wilens, T. E., Frazier, E., & Johnson, M. A. (2002). Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. American Journal of Psychiatry, 159(1), 36-42. https://doi.org/10.1176/appi.ajp.159.1.36
4. Biederman, J., Petty, C. R., Evans, M., Small, J., & Faraone, S. V. (2010). How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Research, 177(3), 299-304. https://doi.org/10.1016/j.psychres.2009.12.010
5. Faraone, S. V., & Biederman, J. (2005). What is the prevalence of adult ADHD? Results of a population screen of 966 adults. Journal of Attention Disorders, 9(2), 384-391. https://doi.org/10.1177/1087054705281478
6. Faraone, S. V., Biederman, J., & Mick, E. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36(2), 159-165. https://doi.org/10.1017/S003329170500471X
7. Faraone, S. V., Spencer, T., Aleardi, M., Pagano, C., & Biederman, J. (2004). Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 24(1), 24-29. https://doi.org/10.1097/01. jcp.0000108984.11879.95
8. Faraone, S. V., Spencer, T. J., Madras, B. K., Zhang-James, Y., & Biederman, J. (2014). Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: A meta-analysis. Molecular Psychiatry, 19(8), 880-889. https://doi.org/10. 1038/mp.2013.126
9. Greydanus, D. E. (2005). Pharmacologic treatment of attention-deficit hyperactivity disorder. Indian Journal of Pediatrics, 72(11), 953-960. https://doi.org/10.1007/BF02731672
10. Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello, B., Abikoff, H. B., Greenhill, L. L., Hechtman, L., Hinshaw, S. P., Pelham, W. E., Wells, K. C., Conners, C. K., Elliott, G. R., Epstein, J. N., Hoza, B., March, J. S., Molina, B. S., Newcorn, J. H., Severe, J. B., Wigal, T., Gibbons, R. D., & Hur, K. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 989-1002. https://doi.org/10.1097/CHI.0b013e3180686d48
11. Molina, B. S., Flory, K., Hinshaw, S. P., Greiner, A. R., Arnold, L. E., Swanson, J. M., Hechtman, L., Jensen, P. S., Vitiello, B., Hoza, B., Pelham, W. E., Elliott, G. R., Wells, K. C., Abikoff, H. B., Gibbons, R. D., Marcus, S., Conners, C. K., Epstein, J. N., Greenhill, L. L., March, J. S., Newcorn, J. H., Severe, J. B., & Wigal, T. (2007). Delinquent behavior and emerging substance use in the MTA at 36 months: Prevalence, course, and treatment effects. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 1028-1040. https://doi.org/10.1097/chi.0b013e3180686d96
12. Molina, B. S., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., & Houck, P. R. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 484-500. https://doi.org/10.1097/CHI.0b013e31819c23d0
13. MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12), 1073-1086. https://doi.org/10.1001/archpsyc.56.12.1073
14. Owens, E. B., Hinshaw, S. P., Kraemer, H. C., Arnold, L. E., Abikoff, H. B., Cantwell, D. P., Conners, C. K., Elliott, G., Greenhill, L. L., Hechtman, L., Hoza, B., Jensen, P. S., March, J. S., Newcorn, J. H., Pelham, W. E., Richters, J. E., Schiller, E. P., Severe, J. B., Swanson, J. M., Vereen, D., Vitiello, B., Wells, K. C., & Wigal, T. (2003). What treatment for whom for ADHD? Moderators of treatment response in the MTA. Journal of Consulting and Clinical Psychology, 71(3), 540-552. https://doi.org/10.1037/0022-006X.71.3.540
15. Wells, K. C., Pelham, W. E., Kotkin, R. A., Hoza, B., Abikoff, H. B., Abramowitz, A., Arnold, L. E., Cantwell, D. P., Conners, C. K., Del Carmen, R., Elliott, G., Greenhill, L. L., Hechtman, L., Hibbs, E., Hinshaw, S. P., Jensen, P. S., March, J. S., Swanson, J. M., & Schiller, E. (2000). Psychosocial treatment strategies in the MTA study: Rationale, methods, and critical issues in design and implementation. Journal of Abnormal Child Psychology, 28(6), 483-505. https://doi.org/10.1023/A:1005174913412
16. Biederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., Wilens, T. E., Frazier, E., & Johnson, M. A. (2002). Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. American Journal of Psychiatry, 159(1), 36-42. https://doi.org/10.1176/appi.ajp.159.1.36
17. Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., & Doyle, A. E. (2000). Attention-deficit/hyperactivity disorder in adults: An overview. Biological Psychiatry, 48(1), 9-20. https://doi.org/10.1016/S0006-3223(00)00889-1
18. Faraone, S. V., Sergeant, J., Gillberg, C., & Biederman, J. (2003). The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry, 2(2), 104-113.
19. Jensen, P. S., Hinshaw, S. P., Swanson, J. M., Greenhill, L. L., Conners, C. K., Arnold, L. E., Abikoff, H. B., Elliott, G., Hechtman, L., Hoza, B., March, J. S., Newcorn, J. H., Severe, J. B., Vitiello, B., Wells, K., & Wigal, T. (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics, 22(1), 60-73. https://doi.org/10.1097/00004703-200102000-00008
20. Molina, B. S., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., Elliott, G. R., Greenhill, L. L., Newcorn, J. H., Wells, K. C., Wigal, T., Gibbons, R. D., Hur, K., & Houck, P. R. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 484-500. https://doi.org/10.1097/CHI.0b013e31819c23d0
21. Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K., Abikoff, H. B., Clevenger, W., Davies, M., Elliott, G. R., Greenhill, L. L., Hechtman, L., Hoza, B., Jensen, P. S., March, J. S., Newcorn, J. H., Owens, E. B., Pelham, W. E., Schiller, E., Severe, J. B., Simpson, S., Vitiello, B., Wells, K., Wigal, T., & Wu M. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 168-179. https://doi.org/10.1097/00004583-200102000-00011
22. Vitiello, B., Severe, J. B., Greenhill, L. L., Arnold, L. E., Abikoff, H. B., Bukstein, O. G., Elliott, G. R., Hechtman, L., Jensen, P. S., Hinshaw, S. P., March, J. S., Newcorn, J. H., Swanson, J. M., & Cantwell, D. P. (2001). Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 188-196. https://doi.org/10. 1097/00004583-200102000-00013